Approval · Notice of Compliance 33066 · 2024
PONSTAN: Notice of Compliance 33066
Issued April 16, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33066
- Date
- April 16, 2024
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph (PM) as per the Advisement Letter dated October 05, 2023 and to convert the PM to the current Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PONSTAN | Not yet assigned | — |
Medicinal ingredients
- MEFENAMIC ACID 250 MG per CAP